DNA Methylome in Human CD4+ T Cells Identifies Transcriptionally

Total Page:16

File Type:pdf, Size:1020Kb

DNA Methylome in Human CD4+ T Cells Identifies Transcriptionally Genes and Immunity (2010) 11, 554–560 & 2010 Macmillan Publishers Limited All rights reserved 1466-4879/10 www.nature.com/gene ORIGINAL ARTICLE DNA methylome in human CD4 þ T cells identifies transcriptionally repressive and non-repressive methylation peaks T Hughes1,4, R Webb1,4, Y Fei1,2,JDWren1 and AH Sawalha1,2,3 1Arthritis & Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; 2Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA and 3US Department of Veterans Affairs Medical Center, Oklahoma City, OK, USA DNA methylation is an epigenetic mark that is critical in determining chromatin accessibility and regulating gene expression. This epigenetic mechanism has an important role in T-cell function. We used genome-wide methylation profiling to characterize the DNA methylome in primary human CD4 þ T cells. We found that only 5% of CpG islands are methylated in CD4 þ T cells, and that DNA methylation peak density is increased in subtelomeric chromosomal regions. We also found an inverse relationship between methylation peak density and chromosomal length. Our data indicate that DNA methylation in gene promoter regions is not always a repressive epigenetic mark. Indeed, about 27% of methylated genes are actively expressed in CD4 þ T cells. We demonstrate that repressive methylation peaks are located closer to the transcription start site (TSS) compared with functionally non-repressive peaks (À893±110 bp versus À1342±218 bp (mean±s.e.m.), P-value o0.05). We also show that both a larger number and an increased CpG island density in promoter sequences predict transcriptional permissiveness of DNA methylation. TSS in the majority of genes with permissive DNA methylation peaks is in DNase I hypersensitive sites, indicating a failure of DNA methylation to induce chromatin inaccessibility in these loci. Genes and Immunity (2010) 11, 554–560; doi:10.1038/gene.2010.24; published online 13 May 2010 Keywords: CD4 þ T cell; DNA methylation; CpG islands; promoter methylation; methylome Introduction regulation of interferon-g, and interleukin (IL)-4 produc- tion, key cytokines produced by Th1 and Th2 cells, DNA methylation is an epigenetic mark that is critical respectively. DNA demethylation of the FOXP3 locus is in determining chromatin accessibility and regulating pivotal for regulatory T-cell differentiation, and demethyla- gene expression. DNA methylation, which refers to the tion of the IL-2 locus is associated with IL-2 production addition of a methyl group to the fifth carbon in cytosine on T-cell activation.8 Defective T-cell DNA methylation residues within CG dinucleotides, is involved in cell results in T-cell autoreactivity and has an important differentiation, imprinting, X-chromosome inactivation, pathogenic role in both drug-induced and idiopathic and suppression of transcriptional noise and ‘parasitic’ lupus, both in human disease and in animal models.7,9,10 DNA.1–4 Abnormalities in the DNA methylation path- Herein, we characterize the DNA methylome in way are associated with pathological consequences. primary human CD4 þ T cells. We map DNA methyla- For example, mutations in the de novo DNA methyl- tion peaks across the genome, and identify genes with transferase DNMT3B result in a syndrome of Immuno- promoter region methylation in CD4 þ T cells using five deficiency, Centromeric instability and Facial anomalies biological replicates. We further identify distinguishing (ICF syndrome).5 A complete deficiency of the DNA features between transcriptionally repressive and non- methyltransferase DNMT1 is incompatible with life. repressive DNA methylation in CD4 þ T cells. Furthermore, acquired abnormalities in DNA methyla- tion are associated with disease conditions, including cancer and autoimmunity.6,7 Results DNA methylation has a critical role in normal T-cell function such as T helper cell differentiation and the We determined genome-wide DNA methylation peaks in primary human CD4 þ T cells using DNA immuno- precipitation (IP) with an anti-5-methylcytidine antibody Correspondence: Dr AH Sawalha, Arthritis & Immunology Pro- coupled with array hybridization. Both input and IP gram, Oklahoma Medical Research Foundation, 825 NE 13th Street, DNA were labeled and co-hybridized to microarray MS#24, Oklahoma City, OK 73104, USA. chips that included B385 000 probes covering all UCSC- E-mail: [email protected] 4These authors contributed equally to this work. annotated CpG islands and promoter regions for all Received 6 January 2010; revised and accepted 2 March 2010; RefSeq genes (NimbleGen, Reykjavı´k, Iceland). The published online 13 May 2010 experiments were carried out using five biological Human CD4 þ T cell DNA methylome T Hughes et al 555 replicates from five normal healthy female donors (age We identified 2902±187 (mean±s.e.m., n ¼ 5) methy- range from 31 to 48 years). Signal intensity data were lation peaks in CD4 þ T-cell DNA. Further, we identified extracted from the scanned images of each array. Scaled 388 genes that have at least one DNA methylation peak log2-ratios of the IP/input DNA were determined from that appears in the À5to þ 1 kb region relative to the signal intensities, and P-values for methylation enrichment transcription start site (TSS) with its center located within were computed using the one-sided Kolmogorov–Smirnov the À5.5 and þ 1.5 kb region in all the five biological test. Methylation peaks were determined. They represent replicates tested. This stringent requirement that all regions with at least two probes with Àlog10 P-values of at genes should be identified in every sample tested has least 2 within a 500 bp window, and a methylation score of the advantage of adding confidence to the target genes at least 2. The methylation score for each peak is the identified near the methylation peaks. average Àlog10 P-values from probes within that peak. We used gene expression data in normal human Several known methylated genetic loci were included CD4 þ T cells (10 biological replicates) available from in our array for quality control. These included the Gene Expression Omnibus, to determine whether there is regions in the HOXA gene cluster, H19/IGF2/ any correlation between gene expression and methyla- KCNQ1 gene cluster and the IGF2R locus. All were tion status. Expression data were available for 202 genes methylated in all five biological replicates used in this with a methylated promoter region in CD4 þ T cells. study. Figure 1a shows the methylation status of the Only 55 genes (27.2%) had at least one transcript H19/IGF2/KCNQ1 gene cluster in our samples. The expressed in normal human CD4 þ T cells. The majority HOXA gene cluster serves both as a positive and of the methylated genes (72.8%) were not expressed. negative control region, as it contains both known Comparatively, when all annotated genes included in the methylated and hypomethylated regions.11 Our data expression array experiment were analyzed, we found confirm this methylation pattern in all five CD4 þ T-cell that 43.7% of genes (9094 out of 20 828 genes examined) DNA samples (Figure 1b). We further validated the were expressed in normal human CD4 þ T cells (w2 ¼ methylation array data in an independent set of 22.0, Po0.0001) (Figure 2a). These findings are consistent samples from another five normal healthy women (age with DNA methylation being largely a repressive range from 22 to 57 years) using bisulfite DNA epigenetic mark in human CD4 þ T cells. However, sequencing of both methylated and hypomethylated 27.2% of methylated genes are transcriptionally active, regions (Figure 1). indicating that DNA methylation is not always asso- Chromosome 11 1,610,0001,680,000 1,750,000 1,820,000 1,890,000 1,960,000 2,030,000 2,100,0002,170,000 2,240,000 2,310,000 2,380,000 2,450,000 2,520,000 2,590,000 2,660,000 2,730,000 2,800,000 2,870,000 2,940,000 3,010,000 3,080,000 3,150,000 3,220,000 Genes HCCA2 LSP1 TNNT3 H19 IGF2 TSPAN32 CD81 TRPM5 KCNQ1 SLC22A18AS NAP1L4 CARS OSBPL5 8.000 6.400 4.000 Sample 1 2.400 0.000 8.000 6.400 Sample 2 4.000 2.400 0.000 8.000 6.400 4.000 Sample 3 2.400 0.000 8.000 6.400 Sample 4 4.000 2.400 0.000 8.000 6.400 Sample 5 4.000 2.400 0.000 1.000 CpG Islands 0.000 80 85 99 80 84 91 94 87 93 91 91 78 83 91 94 79 83 92 85 79 Chr11: 2,411,956-2,412,208 Methylation (%) 0 255075100 Figure 1 Methylation enrichment signals represented as Àlog10 P-value scores in CD4 þ T-cell DNA from five normal healthy participants in (a) the H19/IGF2/KCNQ1 genetic locus on chromosome 11, and (b) the HOXA gene cluster on chromosome 7. Bisulfite DNA sequencing was used to validate the methylation status in methylated regions within the HOXA3 gene and the KCNQ1/TRPM5 promoter region, and hypomethylated regions in the HOXA1 and HOXA13 promoter regions in an independent set of samples. Genes and Immunity Human CD4 þ T cell DNA methylome T Hughes et al 556 Chromosome 7 27,072,000 27,080,000 27,088,000 27,096,000 27,104,000 27,112,000 27,120,000 27,128,000 27,136,000 27,144,000 27,152,000 27,160,000 27,168,000 27,176,000 27,184,000 27,192,000 27,200,000 27,208,000 27,216,000 27,224,000 27,232,000 27,240,000 27,248,000 27,256,000 HOX Genes A1 A2A3 A4 A5 A6 A7 A9 A10 A11 A13 EVX1 5.500 3.600 Sample 1 2.400 1.200 0.000 5.500 3.600 Sample 2 2.400 1.200 0.000 5.500 3.600 Sample 3 2.400 1.200 0.000 5.500 3.600 Sample 4 2.400 1.200 0.000 5.500 3.600 Sample 5 2.400 1.200 0.000 1.000 CpG Islands 0.000 1002010012211100 79 97 90 78 89 30 88 90 79 90 89 91 14 3 2 13 0 0 17 17 0 2 0 0000000000000000 88 99 95 95 97 85 95 96 90 93 97 92 13 4 10 16 0 15 3 3 0 0 0 0000000000000000 82 94 97 93 95 57 88 94 92 93 95 82 18 8 5 0 15 11 0 9 0 0 0 30000000000000000 85 95 98 84 93 57 88 91 94 93 94 93 504841404800 0000000000000000 74 87 94 86 84 46 91 93 84 94 94 95 14 5 12 18 3 0 9 0 0 0 0 Chr7: 27,101,779-27,102,082 Chr7: 27,129,376-27,129,708 Chr7: 27,206,717-27,207,948 Methylation (%) 0 25 50 75 100 Figure 1 Continued.
Recommended publications
  • Aberrant Methylation Underlies Insulin Gene Expression in Human Insulinoma
    ARTICLE https://doi.org/10.1038/s41467-020-18839-1 OPEN Aberrant methylation underlies insulin gene expression in human insulinoma Esra Karakose1,6, Huan Wang 2,6, William Inabnet1, Rajesh V. Thakker 3, Steven Libutti4, Gustavo Fernandez-Ranvier 1, Hyunsuk Suh1, Mark Stevenson 3, Yayoi Kinoshita1, Michael Donovan1, Yevgeniy Antipin1,2, Yan Li5, Xiaoxiao Liu 5, Fulai Jin 5, Peng Wang 1, Andrew Uzilov 1,2, ✉ Carmen Argmann 1, Eric E. Schadt 1,2, Andrew F. Stewart 1,7 , Donald K. Scott 1,7 & Luca Lambertini 1,6 1234567890():,; Human insulinomas are rare, benign, slowly proliferating, insulin-producing beta cell tumors that provide a molecular “recipe” or “roadmap” for pathways that control human beta cell regeneration. An earlier study revealed abnormal methylation in the imprinted p15.5-p15.4 region of chromosome 11, known to be abnormally methylated in another disorder of expanded beta cell mass and function: the focal variant of congenital hyperinsulinism. Here, we compare deep DNA methylome sequencing on 19 human insulinomas, and five sets of normal beta cells. We find a remarkably consistent, abnormal methylation pattern in insu- linomas. The findings suggest that abnormal insulin (INS) promoter methylation and altered transcription factor expression create alternative drivers of INS expression, replacing cano- nical PDX1-driven beta cell specification with a pathological, looping, distal enhancer-based form of transcriptional regulation. Finally, NFaT transcription factors, rather than the cano- nical PDX1 enhancer complex, are predicted to drive INS transactivation. 1 From the Diabetes Obesity and Metabolism Institute, The Department of Surgery, The Department of Pathology, The Department of Genetics and Genomics Sciences and The Institute for Genomics and Multiscale Biology, The Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
    [Show full text]
  • Research Article Characterization, Tissue Expression, and Imprinting Analysis of the Porcine CDKN1C and NAP1L4 Genes
    Hindawi Publishing Corporation Journal of Biomedicine and Biotechnology Volume 2012, Article ID 946527, 7 pages doi:10.1155/2012/946527 Research Article Characterization, Tissue Expression, and Imprinting Analysis of the Porcine CDKN1C and NAP1L4 Genes Shun Li,1 Juan Li,1 Jiawei Tian,1 Ranran Dong,1 Jin Wei,1 Xiaoyan Qiu,2 and Caode Jiang2 1 School of Life Science, Southwest University, Chongqing 400715, China 2 College of Animal Science and Technology, Southwest University, Chongqing 400715, China Correspondence should be addressed to Caode Jiang, [email protected] Received 4 August 2011; Revised 25 October 2011; Accepted 15 November 2011 Academic Editor: Andre Van Wijnen Copyright © 2012 Shun Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CDKN1C and NAP1L4 in human CDKN1C/KCNQ1OT1 imprinted domain are two key candidate genes responsible for BWS (Beckwith-Wiedemann syndrome) and cancer. In order to increase understanding of these genes in pigs, their cDNAs are characterized in this paper. By the IMpRH panel, porcine CDKN1C and NAP1L4 genes were assigned to porcine chromosome 2, closely linked with IMpRH06175 and with LOD of 15.78 and 17.94, respectively. By real-time quantitative RT-PCR and polymorphism-based method, tissue and allelic expression of both genes were determined using F1 pigs of Rongchang and Landrace reciprocal crosses. The transcription levels of porcine CDKN1C and NAP1L4 were significantly higher in placenta than in other neonatal tissues (P<0.01) although both genes showed the highest expression levels in the lung and kidney of one- month pigs (P<0.01).
    [Show full text]
  • Redefining the Specificity of Phosphoinositide-Binding by Human
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.20.163253; this version posted June 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Redefining the specificity of phosphoinositide-binding by human PH domain-containing proteins Nilmani Singh1†, Adriana Reyes-Ordoñez1†, Michael A. Compagnone1, Jesus F. Moreno Castillo1, Benjamin J. Leslie2, Taekjip Ha2,3,4,5, Jie Chen1* 1Department of Cell & Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801; 2Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205; 3Department of Biophysics, Johns Hopkins University, Baltimore, MD 21218; 4Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21205; 5Howard Hughes Medical Institute, Baltimore, MD 21205, USA †These authors contributed equally to this work. *Correspondence: [email protected]. bioRxiv preprint doi: https://doi.org/10.1101/2020.06.20.163253; this version posted June 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. ABSTRACT Pleckstrin homology (PH) domains are presumed to bind phosphoinositides (PIPs), but specific interaction with and regulation by PIPs for most PH domain-containing proteins are unclear. Here we employed a single-molecule pulldown assay to study interactions of lipid vesicles with full-length proteins in mammalian whole cell lysates.
    [Show full text]
  • Snps) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction S
    Supplemental material to this article can be found at: http://dmd.aspetjournals.org/content/suppl/2018/07/06/dmd.118.082164.DC1 1521-009X/46/9/1372–1381$35.00 https://doi.org/10.1124/dmd.118.082164 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 46:1372–1381, September 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction s Duan Liu, Sisi Qin, Balmiki Ray,1 Krishna R. Kalari, Liewei Wang, and Richard M. Weinshilboum Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics (D.L., S.Q., B.R., L.W., R.M.W.) and Division of Biomedical Statistics and Informatics, Department of Health Sciences Research (K.R.K.), Mayo Clinic, Rochester, Minnesota Received April 22, 2018; accepted June 28, 2018 ABSTRACT Downloaded from CYP1A1 expression can be upregulated by the ligand-activated aryl fashion. LCLs with the AA genotype displayed significantly higher hydrocarbon receptor (AHR). Based on prior observations with AHR-XRE binding and CYP1A1 mRNA expression after 3MC estrogen receptors and estrogen response elements, we tested treatment than did those with the GG genotype. Electrophoretic the hypothesis that single-nucleotide polymorphisms (SNPs) map- mobility shift assay (EMSA) showed that oligonucleotides with the ping hundreds of base pairs (bp) from xenobiotic response elements AA genotype displayed higher LCL nuclear extract binding after (XREs) might influence AHR binding and subsequent gene expres- 3MC treatment than did those with the GG genotype, and mass dmd.aspetjournals.org sion.
    [Show full text]
  • Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications
    Stem Cell Rev and Rep DOI 10.1007/s12015-016-9662-8 Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications Behnam Ahmadian Baghbaderani 1 & Adhikarla Syama2 & Renuka Sivapatham3 & Ying Pei4 & Odity Mukherjee2 & Thomas Fellner1 & Xianmin Zeng3,4 & Mahendra S. Rao5,6 # The Author(s) 2016. This article is published with open access at Springerlink.com Abstract We have recently described manufacturing of hu- help determine which set of tests will be most useful in mon- man induced pluripotent stem cells (iPSC) master cell banks itoring the cells and establishing criteria for discarding a line. (MCB) generated by a clinically compliant process using cord blood as a starting material (Baghbaderani et al. in Stem Cell Keywords Induced pluripotent stem cells . Embryonic stem Reports, 5(4), 647–659, 2015). In this manuscript, we de- cells . Manufacturing . cGMP . Consent . Markers scribe the detailed characterization of the two iPSC clones generated using this process, including whole genome se- quencing (WGS), microarray, and comparative genomic hy- Introduction bridization (aCGH) single nucleotide polymorphism (SNP) analysis. We compare their profiles with a proposed calibra- Induced pluripotent stem cells (iPSCs) are akin to embryonic tion material and with a reporter subclone and lines made by a stem cells (ESC) [2] in their developmental potential, but dif- similar process from different donors. We believe that iPSCs fer from ESC in the starting cell used and the requirement of a are likely to be used to make multiple clinical products. We set of proteins to induce pluripotency [3]. Although function- further believe that the lines used as input material will be used ally identical, iPSCs may differ from ESC in subtle ways, at different sites and, given their immortal status, will be used including in their epigenetic profile, exposure to the environ- for many years or even decades.
    [Show full text]
  • Letters to the Editor J Med Genet: First Published As 10.1136/Jmg.37.3.231 on 1 March 2000
    210 Letters Letters to the Editor J Med Genet: first published as 10.1136/jmg.37.3.231 on 1 March 2000. Downloaded from J Med Genet 2000;37:210–212 No evidence of germline PTEN three reasons: somatic mutations have been found in PTEN in prostate tumours; germline mutations in Cowden mutations in familial prostate cancer disease produce a phenotype (although with no evidence of an associated susceptibility to prostate cancer); and PTEN deficient mice exhibit prostate abnormalities. We have therefore screened the Cancer Research Campaign/British EDITOR—Prostate cancer is the second most common Prostate Group (CRC/BPG) UK Familial Prostate Cancer cause of male cancer mortality in the UK.1 Current indica- Study samples for evidence of PTEN mutations. tions are that like many common cancers, prostate cancer The CRC/BPG UK Familial Prostate Cancer Study has has an inherited component.2 Segregation analysis has led collected lymphocyte DNA from 188 subjects from 50 to the proposed model of at least one highly penetrant, prostate cancer families. These families were chosen dominant gene (with an estimated 88% penetrance for because each contained three or more cases of prostate prostate cancer by the age of 85 in the highly susceptible cancer at any age or related sib pairs where at least one man population). Such a gene or genes would account for an was less than 67 (original criterion was 65) years old at estimated 43% of cases diagnosed at less than 55 years.2 diagnosis. In fact, the majority of the clusters consist of One prostate cancer susceptibility locus (HPC1) has been aVected sib pairs, with DNA often only available from reported on 1q24-253 and confirmed by Cooney et al4 and cases.
    [Show full text]
  • Mclean, Chelsea.Pdf
    COMPUTATIONAL PREDICTION AND EXPERIMENTAL VALIDATION OF NOVEL MOUSE IMPRINTED GENES A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Chelsea Marie McLean August 2009 © 2009 Chelsea Marie McLean COMPUTATIONAL PREDICTION AND EXPERIMENTAL VALIDATION OF NOVEL MOUSE IMPRINTED GENES Chelsea Marie McLean, Ph.D. Cornell University 2009 Epigenetic modifications, including DNA methylation and covalent modifications to histone tails, are major contributors to the regulation of gene expression. These changes are reversible, yet can be stably inherited, and may last for multiple generations without change to the underlying DNA sequence. Genomic imprinting results in expression from one of the two parental alleles and is one example of epigenetic control of gene expression. So far, 60 to 100 imprinted genes have been identified in the human and mouse genomes, respectively. Identification of additional imprinted genes has become increasingly important with the realization that imprinting defects are associated with complex disorders ranging from obesity to diabetes and behavioral disorders. Despite the importance imprinted genes play in human health, few studies have undertaken genome-wide searches for new imprinted genes. These have used empirical approaches, with some success. However, computational prediction of novel imprinted genes has recently come to the forefront. I have developed generalized linear models using data on a variety of sequence and epigenetic features within a training set of known imprinted genes. The resulting models were used to predict novel imprinted genes in the mouse genome. After imposing a stringency threshold, I compiled an initial candidate list of 155 genes.
    [Show full text]
  • Is Associated with Hypomethylation At
    797 ORIGINAL ARTICLE J Med Genet: first published as 10.1136/jmg.40.11.797 on 19 November 2003. Downloaded from Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith–Wiedemann syndrome N Diaz-Meyer, C D Day, K Khatod, E R Maher, W Cooper, W Reik, C Junien, G Graham, E Algar, V M Der Kaloustian, M J Higgins ............................................................................................................................... J Med Genet 2003;40:797–801 Context: Beckwith–Wiedemann syndrome (BWS) arises by several genetic and epigenetic mechanisms affecting the balance of imprinted gene expression in chromosome 11p15.5. The most frequent alteration associated with BWS is the absence of methylation at the maternal allele of KvDMR1, an intronic CpG island within the KCNQ1 gene. Targeted deletion of KvDMR1 suggests that this locus is an imprinting control region (ICR) that regulates multiple genes in 11p15.5. Cell culture based enhancer blocking assays indicate that KvDMR1 may function as a methylation modulated chromatin insulator and/or silencer. See end of article for Objective: To determine the potential consequence of loss of methylation (LOM) at KvDMR1 in the authors’ affiliations ....................... development of BWS. Methods: The steady state levels of CDKN1C gene expression in fibroblast cells from normal individuals, Correspondence to: and from persons with BWS who have LOM at KvDMR1, was determined by both real time quantitative M J Higgins, Department of Cancer Genetics, polymerase chain reaction (qPCR) and ribonuclease protection assay (RPA). Methylation of the CDKN1C Roswell Park Cancer promoter region was assessed by Southern hybridisation using a methylation sensitive restriction Institute, Buffalo, NY endonuclease. 14263, USA; michael.higgins@ Results: Both qPCR and RPA clearly demonstrated a marked decrease (86–93%) in the expression level of roswellpark.org the CDKN1C gene in cells derived from patients with BWS, who had LOM at KvDMR1.
    [Show full text]
  • Goat Anti-ORP5 (OBPH1) Antibody Peptide-Affinity Purified Goat Antibody Catalog # Af1761a
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 Goat Anti-ORP5 (OBPH1) Antibody Peptide-affinity purified goat antibody Catalog # AF1761a Specification Goat Anti-ORP5 (OBPH1) Antibody - Product Information Application WB Primary Accession Q9H0X9 Other Accession NP_001137535, 114879, 79196 (mouse) Reactivity Human Predicted Mouse, Rat, Dog Host Goat Clonality Polyclonal Concentration 100ug/200ul Isotype IgG Calculated MW 98616 AF1761a (2 µg/ml) staining of human spleen lysate (35 µg protein in RIPA buffer). Primary Goat Anti-ORP5 (OBPH1) Antibody - Additional incubation was 1 hour. Detected by Information chemiluminescence. Gene ID 114879 Goat Anti-ORP5 (OBPH1) Antibody - Other Names Background Oxysterol-binding protein-related protein 5, ORP-5, OSBP-related protein 5, This gene encodes a member of the Oxysterol-binding protein homolog 1, oxysterol-binding protein (OSBP) family, a OSBPL5, KIAA1534, OBPH1, ORP5 group of intracellular lipid receptors. Most members contain an N-terminal pleckstrin Format homology domain and a highly conserved 0.5 mg IgG/ml in Tris saline (20mM Tris C-terminal OSBP-like sterol-binding domain. pH7.3, 150mM NaCl), 0.02% sodium azide, Transcript variants encoding different isoforms with 0.5% bovine serum albumin have been identified. Storage Maintain refrigerated at 2-8°C for up to 6 Goat Anti-ORP5 (OBPH1) Antibody - months. For long term storage store at References -20°C in small aliquots to prevent freeze-thaw cycles. Genome-wide association study of alcohol dependence implicates a region on Precautions chromosome 11. Edenberg HJ, et al. Alcohol Goat Anti-ORP5 (OBPH1) Antibody is for Clin Exp Res, 2010 May.
    [Show full text]
  • Genome-Wide Expression Profiling Establishes Novel Modulatory Roles
    Batra et al. BMC Genomics (2017) 18:252 DOI 10.1186/s12864-017-3635-4 RESEARCHARTICLE Open Access Genome-wide expression profiling establishes novel modulatory roles of vitamin C in THP-1 human monocytic cell line Sakshi Dhingra Batra, Malobi Nandi, Kriti Sikri and Jaya Sivaswami Tyagi* Abstract Background: Vitamin C (vit C) is an essential dietary nutrient, which is a potent antioxidant, a free radical scavenger and functions as a cofactor in many enzymatic reactions. Vit C is also considered to enhance the immune effector function of macrophages, which are regarded to be the first line of defence in response to any pathogen. The THP- 1 cell line is widely used for studying macrophage functions and for analyzing host cell-pathogen interactions. Results: We performed a genome-wide temporal gene expression and functional enrichment analysis of THP-1 cells treated with 100 μM of vit C, a physiologically relevant concentration of the vitamin. Modulatory effects of vitamin C on THP-1 cells were revealed by differential expression of genes starting from 8 h onwards. The number of differentially expressed genes peaked at the earliest time-point i.e. 8 h followed by temporal decline till 96 h. Further, functional enrichment analysis based on statistically stringent criteria revealed a gamut of functional responses, namely, ‘Regulation of gene expression’, ‘Signal transduction’, ‘Cell cycle’, ‘Immune system process’, ‘cAMP metabolic process’, ‘Cholesterol transport’ and ‘Ion homeostasis’. A comparative analysis of vit C-mediated modulation of gene expression data in THP-1cells and human skin fibroblasts disclosed an overlap in certain functional processes such as ‘Regulation of transcription’, ‘Cell cycle’ and ‘Extracellular matrix organization’, and THP-1 specific responses, namely, ‘Regulation of gene expression’ and ‘Ion homeostasis’.
    [Show full text]
  • Associated with Spherical Equivalent
    Molecular Vision 2016; 22:783-796 <http://www.molvis.org/molvis/v22/783> © 2016 Molecular Vision Received 20 August 2015 | Accepted 12 July 2016 | Published 14 July 2016 Variation in PTCHD2, CRISP3, NAP1L4, FSCB, and AP3B2 associated with spherical equivalent Fei Chen,1 Priya Duggal,1 Barbara E.K. Klein,2 Kristine E. Lee,2 Barbara Truitt,3 Ronald Klein,2 Sudha K. Iyengar,3 Alison P. Klein1,4,5 1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; 2Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI; 3Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH; 4Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; 5Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD Purpose: Ocular refraction is measured in spherical equivalent as the power of the external lens required to focus images on the retina. Myopia (nearsightedness) and hyperopia (farsightedness) are the most common refractive errors, and the leading causes of visual impairment and blindness in the world. The goal of this study is to identify rare and low-frequency variants that influence spherical equivalent. Methods: We conducted variant-level and gene-level quantitative trait association analyses for mean spherical equiva- lent, using data from 1,560 individuals in the Beaver Dam Eye Study. Genotyping was conducted using the Illumina exome array. We analyzed 34,976 single nucleotide variants and 11,571 autosomal genes across the genome, using single-variant tests as well as gene-based tests. Results: Spherical equivalent was significantly associated with five genes in gene-based analysis: PTCHD2 at 1p36.22 (p = 3.6 × 10−7), CRISP3 at 6p12.3 (p = 4.3 × 10−6), NAP1L4 at 11p15.5 (p = 3.6 × 10−6), FSCB at 14q21.2 (p = 1.5 × 10−7), and AP3B2 at 15q25.2 (p = 1.6 × 10−7).
    [Show full text]
  • Comparative Analysis of Sequence Characteristics of Imprinted Genes in Human, Mouse, and Cattle
    Mamm Genome (2007) 18:538–547 DOI 10.1007/s00335-007-9039-z Comparative analysis of sequence characteristics of imprinted genes in human, mouse, and cattle Hasan Khatib Æ Ismail Zaitoun Æ Eui-Soo Kim Received: 28 February 2007 / Accepted: 23 May 2007 / Published online: 26 July 2007 Ó Springer Science+Business Media, LLC 2007 Abstract Genomic imprinting is an epigenetic mecha- in agreement with previous reports for human and mouse nism that results in monoallelic expression of genes imprinted regions. Long interspersed nuclear elements depending on parent-of-origin of the allele. Although the (LINEs) and long terminal repeats (LTRs) were found to be conservation of genomic imprinting among mammalian significantly underrepresented in imprinted genes com- species has been widely reported for many genes, there is pared to control genes, contrary to reports on human and accumulating evidence that some genes escape this con- mouse. Of considerable significance was the finding of servation. Most known imprinted genes have been identi- highly conserved tandem repeats in nine of the genes fied in the mouse and human, with few imprinted genes imprinted in all three species. reported in cattle. Comparative analysis of genomic imprinting across mammalian species would provide a powerful tool for elucidating the mechanisms regulating the unique expression of imprinted genes. In this study we Introduction analyzed the imprinting of 22 genes in human, mouse, and cattle and found that in only 11 was imprinting conserved Genomic imprinting is an epigenetic mechanism that across the three species. In addition, we analyzed the results in monoallelic expression of genes depending on occurrence of the sequence elements CpG islands, C + G parent-of-origin of the allele.
    [Show full text]